FUJIFILM Biotechnologies, a contract development and manufacturing organisation (CDMO), has announced an expansion of its global partnership with immunology company argenx SE. Under the agreement, FUJIFILM Biotechnologies will begin manufacturing efgartigimod drug substance in Holly Springs, North Carolina, in 2028.
“In pharmaceutical consulting everybody’s just doing their own thing. It’s the Wild West compared to what it should be.” – Ray Sison Ray Sison, founder of SCxCMC exclusively speaks to the PharmaSource podcast about the launch of the Society of
Lilly has announced plans to invest $5 billion to establish a new manufacturing facility west of Richmond, Virginia. The site will be the company’s first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for its bioconjugate platform
Kindeva, a global CDMO and drug delivery specialist, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park, Loughborough. The site marks a major expansion of the company’s metered-dose inhaler (MDI) services, focusing on the
Wheeler Bio, a U.S.-based contract development and biomanufacturing organisation (CDMO), has signed an agreement with MindImmune Therapeutics to provide integrated process development and cGMP drug substance manufacturing services. The work will be delivered through Wheeler’s ModularCMC™ platform, which focuses on
Download the CDMO Periodic Table: 118 essential elements for contract development manufacturing success
GSK announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years. The investment includes a new $1.2 billion commitment to advanced manufacturing facilities and AI and advanced
ProBioGen and the Berlin Institute of Health at Charité (BIH) have announced that the company has been awarded the contract to operate the process development and GMP production facility at the Berlin Center for Gene and Cell Therapies (BC GCT).
Piramal Pharma Solutions, a global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd, has announced the acquisition of a Korsch XM-12 bilayer tablet press for its Morpeth, UK site. The facility supports the company’s integrated offering
HHS Secretary Robert F. Kennedy Jr.’s reconstituted Advisory Committee on Immunization Practices (ACIP) is expected to vote September 18-19 to delay routine hepatitis B vaccination from birth to age 4, potentially ending a 30-year universal newborn vaccination program that has
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
